4.5 Article

Alanine transferase: An independent indicator of adiposity related comorbidity risk in youth

Journal

JOURNAL OF DIABETES
Volume 7, Issue 5, Pages 649-656

Publisher

WILEY
DOI: 10.1111/1753-0407.12221

Keywords

adiposity; alanine transferase; cardiovascular disease; diabetes mellitus in youth; obesity

Funding

  1. AMDeC the Starr Foundation
  2. NIH [UL1RR0023568, UL1RR024156]

Ask authors/readers for more resources

BackgroundElevated levels of alanine aminotransferase (ALT) are associated with obesity and are often a consequence of non-alcoholic fatty liver disease (NAFLD). The aim of the present study was to assess the relationship between ALT and risk factors for adiposity-related co-morbidities in a diverse population of middle school children. MethodsWe measured height, weight, body fatness (bioelectrical impedance), waist circumference, insulin sensitivity, phase 1 insulin release (acute insulin response following intravenous glucose), beta-cell function (acute insulin response corrected for insulin sensitivity), ALT, lipid profiles, and circulating concentrations of interleukin-6 (IL-6), C-reactive protein, adiponectin, and tumor necrosis factor- (TNF-) in a multi-ethnic/racial population of 106 middle school students (aged 11-14 years, 45female) of varying body mass indexes (BMI). ResultsAlanine aminotransferase was significantly correlated with BMI, % body fat, fat mass, waist circumference, fasting insulin, insulin resistance, triglycerides, and was inversely correlated with high-density lipoprotein cholesterol in children, even though all values of ALT were normal (range of 4.0-33.0U/L). ALT was significantly higher in males than females even when corrected for body fatness. Significant correlations with lipids and insulin resistance persisted even when adjusted for age, gender, and body fatness. ConclusionEven within the normative range, ALT levels were significantly correlated with anthropomorphic and biochemical risk factors for adiposity-related co-morbidities in youth. Therefore, because ALT is correlated with dyslipidemia, insulin resistance, and central fat distribution, it might also serve as a marker of risk for adiposity-related co-morbidities beyond NAFLD. ?? ??????????(alanine aminotransferase,ALT)?????????,?????????????(non-alcoholic fatty liver disease,NAFLD)??????????????????????ALT?????????????????? ?????106?????(BMI)?????/??????(???11-14?,?45???)???????????(?????)???????????1??????(????????????????)?-????(?????????????????)?ALT?????????????-6(IL-6)?C-????????????????-(TNF-)??? ?????,ALT?BMI???????????????????????????????????,???????????????,?????ALT??????(???4.0-33.0U/L)????????,??ALT??????????????????????????,???????????????? ??????,??ALT????????,????????????????????????????????,??ALT?????????????????????,????NAFLD????????????????????????

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available